BPO 0.00% 0.3¢ bioprospect limited

charry3 any news, page-7

  1. 1,731 Posts.
    re: attn: charry3 I agree to some extent. The (QCIDE)product has been tested however and works. It does not have to undergo any more testing or approvals unlike many other bios. It just needs someone to sign on the line and the product will be away.

    It will take a while for revenue to build up after contracts are signed but again no more tests or approvals required. The price should spike on a positive announcment like EPT, SLT,AGX etc.. short term.
    If no announcment forthcoming soon price will hover btn 8-10cents until one comes.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.